Where does Verdant Bioproducts Limited rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Verdant Bioproducts Limited ranks #38,184 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Verdant Bioproducts Limited hold?

Verdant Bioproducts Limited holds 7 US utility patents granted between 2015 and 2020, spanning 8 technology areas.

What is Verdant Bioproducts Limited's Innovation Score?

Verdant Bioproducts Limited has an Innovation Score of 27.0 out of 100 (22nd percentile of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Is Verdant Bioproducts Limited's patent grant rate increasing or decreasing?

Verdant Bioproducts Limited's recent grant velocity is -83% compared to the prior five-year period (grant years, not application filing dates). Grant activity has slowed relative to earlier years.

What does claim depth mean for Verdant Bioproducts Limited's patents?

Verdant Bioproducts Limited's patents average 16.4 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Verdant Bioproducts Limited patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Verdant Bioproducts Limited

Q: What technology areas does Verdant Bioproducts Limited focus on?

Verdant Bioproducts Limited's top technology area is C12P (Fermentation OR Enzyme-using Processes TO Synthesise A Desired Chemical Compound OR Composition OR TO Separate Optical Isomers From A Racemic Mixture) with 7 patents. Grants appear in 8 CPC subclasses total.

USPTO PatentsView assignee record - 7 granted patents across 8 technology areas, recorded in grant years 2015–2020. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: C12P (Fermentation OR Enzyme-using Processes TO Synthesise A Desired Chemical Compound OR Composition OR TO Separate Optical Isomers From A Racemic Mixture).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Verdant ranks #38,184 of 49,997 tracked US assignees by granted-patent volume, with 7 patents across 8 technology areas.

#38,184
of 49,997 US assignees by volume: 22nd percentile
by Innovation Score (27.0/100): 16.4
avg claims per patent: -83%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R38184 · Foreign Corporation #38,184 · 7 grants

GRANTS-MICRO · LOWER-Q · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-RICH · TYPE-FRNCORP · VEL-DROP · BOOK-FULL

GRANTS-MICRO 7 grants
LOWER-Q #38,184/49,997
PHOTO-FINISH Venture Lending &…
CPC-NARROW C12P · 8 areas
INNOV-THIN 27.0/100
CLAIMS-RICH 16.4 claims/avg
TYPE-FRNCORP Foreign Corp
VEL-DROP -83% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Venture Lending & Leasing Viii, Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

Qualcomm Incorporated · highest

85
Verdant Bioproducts · this assignee

27
3D Lighting… · lowest

7

What this shows Verdant's Innovation Score is 27.0/100 (22nd percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Where Verdant's grants concentrate

Verdant Bioproducts Limited is a focused PatentsView assignee: 8 CPC subclasses with 100% of grants classified under C12P (Fermentation OR Enzyme-using Processes TO Synthesise A Desired Chemical Compound OR Composition OR TO Separate Optical Isomers From A Racemic Mixture). Peak complete grant year is 2018 (4 grants) versus a trough of 1 in 2015. By volume, Verdant sits between Venture Lending & Leasing Viii, Inc. and Vertex, Inc..

Venture Lending &…

7
Ventus Networks

7
Veoneer US Safety…

7
VERA

7
Verisiti

7
Versionone

7
Vertellus Holdings

7
Vertex

7
Verdant Bioproduc… ◀

7

What this shows Verdant holds 7 patents at rank #38,137, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Verdant

By rank, the assignees closest to #38,137 in granted patent volume.

Leaders in C12P (Fermentation OR Enzyme-using Processes TO Synthesise A De…)

Other assignees with the most granted patents in Verdant's primary technology class.

Verdant's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

27 22nd percentile higher than 22% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2020

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Verdant Bioproducts Limited patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	1	14.3%
2016	1	14.3%
2018	4	57.1%
2020	1	14.3%

Which technologies does Verdant Bioproducts Limited patent most?

C12P - Fermentation OR Enzyme-using Processes TO Synthesise A Desired Chemical Compound OR Composition OR TO Separate Optical Isomers From A Racemic Mixture 7

C12N - Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media 5

Y02E - Reduction OF Greenhouse GAS [GHG] Emissions, Related TO Energy Generation, Transmission OR Distribution 4

C12R - Indexing Scheme Associated With Subclasses C12c - C12q, Relating TO Microorganisms 4

Y02P - Climate Change Mitigation Technologies IN THE Production OR Processing OF Goods 3

C10L - Fuels NOT Otherwise Provided FOR; Natural GAS; Synthetic Natural GAS Obtained BY Processes NOT Covered BY Subclasses C10g OR C10K; Liquified Petroleum GAS; USE OF Additives TO Fuels OR FIRES; Fire-lighters 1

C08G - Macromolecular Compounds Obtained Otherwise Than BY Reactions Only Involving Unsaturated Carbon-to-carbon Bonds 1

B01D - Separation 1

Top 8 of 8 technology areas

Where it ranks

Overall rank by patents

#38,184

of 49,997 tracked assignees

Innovation Score

27.0 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

What to do with this data

Verdant Bioproducts Limited's patent record in context - here's where to go next.

Verdant Bioproducts Limited's lead technology class is C12P (Fermentation OR Enzyme-using Processes TO Synthesise A Desired Chemical Compound OR Composition OR TO Separate Optical Isomers From A Racemic Mixture), 100% of its portfolio - see every assignee active in that class. Explore C12P
Ranked #38,184 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Verdant Bioproducts Limited against Venture Lending & Leasing Viii, Inc., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 27.0/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.